Market Performance
The stock market saw a steady session today, with Fabtech Technologies IPO attracting significant attention from investors. The issue gained momentum on the second day of bidding, reflecting strong investor interest in this Mumbai-based pharmaceutical equipment solutions provider.
The IPO subscription numbers indicate that the market is responding well, even as broader indices traded with mixed sentiments.
Fabtech Technologies IPO Subscription Details
On Day 2, the IPO achieved 93% overall subscription, with bids received for 1,12,43,025 shares against 1,20,60,000 shares on offer, according to NSE data.
Break-up of investor participation:
- Qualified Institutional Buyers (QIBs): 94% subscribed
- Non-Institutional Investors (NIIs): 65% subscribed
- Retail Individual Investors (RIIs): 104% subscribed
The figures highlight broad-based interest across all investor categories, with retail investors slightly oversubscribing their quota.
IPO Details and Pricing
Fabtech Technologies has launched a ₹230-crore IPO, entirely a fresh issue, with up to 1.2 crore equity shares on offer. The price band has been fixed at ₹181–191 per share.
The IPO proceeds are earmarked for:
- Funding working capital requirements
- Supporting inorganic growth initiatives through acquisitions
- General corporate purposes
This capital infusion will strengthen the company’s operational capacity and growth trajectory.
About Fabtech Technologies
Fabtech Technologies offers end-to-end solutions for pharmaceutical equipment, including:
- Designing
- Engineering
- Procurement
- Installation and testing
The company serves a diverse international clientele, having completed 35 projects till June 2024 across countries such as Saudi Arabia, Egypt, Algeria, Bangladesh, Ethiopia, Sri Lanka, and the UAE.
Unistone Capital is handling the IPO as the sole book-running lead manager for the issue.
Summary of Key Points
- Fabtech Technologies IPO 93% subscribed on Day 2
- Shares on offer: 1,20,60,000; Bids received: 1,12,43,025
- Price band: ₹181–191 per share; total IPO size ₹230 crore
- QIB subscription: 94%, NII: 65%, RII: 104%
- Proceeds allocated to working capital, acquisitions, and corporate purposes
- Company has completed 35 international projects till June 2024
Easy & quick
Leave A Comment?